[HTML] nih.gov

[HTML][HTML] Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - medRxiv - ncbi.nlm.nih.gov
Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …
被引用次数：20 相关文章

Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - medRxiv, 2021 - medrxiv.org
ABSTRACT Background Several Canadian provinces are extending the interval between
COVID-19 vaccine doses to increase population vaccine coverage more rapidly. However …

Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang… - … : the preprint server …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …
[HTML] europepmc.org

[HTML][HTML] Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - 2021 - europepmc.org
Background Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …

Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine.

MA Brockman, F Mwimanzi, Y Sang, K Ng… - Medrxiv: the Preprint …, 2021 - europepmc.org
Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …